Origo Biopharma Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
Origo Biopharma General Information
Description
Developer of organ-restricted drugs intended to address unmet medical needs related to cancer and fibrosis. The company's drug addresses health disorders related to TGF-β signaling dysfunction, cancer, and fibrosis, enabling people to get cures from devastating medical conditions.
Contact Information
Website
www.origobiopharma.comCorporate Office
- Parque Empresarial de Touro
- Parcelas 26-27, Fonte Díaz
- 15822 A Coruna
- Spain
Corporate Office
- Parque Empresarial de Touro
- Parcelas 26-27, Fonte Díaz
- 15822 A Coruna
- Spain
Origo Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 26-Oct-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 07-Jul-2020 | Completed | Clinical Trials - Phase 1 |
Origo Biopharma Signals
Origo Biopharma Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Asabys Partners | Venture Capital | Minority | ||
| XesGalicia | Venture Capital | Minority |
Origo Biopharma FAQs
-
When was Origo Biopharma founded?
Origo Biopharma was founded in 2017.
-
Where is Origo Biopharma headquartered?
Origo Biopharma is headquartered in A Coruna, Spain.
-
What is the size of Origo Biopharma?
Origo Biopharma has 10 total employees.
-
What industry is Origo Biopharma in?
Origo Biopharma’s primary industry is Biotechnology.
-
Is Origo Biopharma a private or public company?
Origo Biopharma is a Private company.
-
What is Origo Biopharma’s current revenue?
The current revenue for Origo Biopharma is .
-
How much funding has Origo Biopharma raised over time?
Origo Biopharma has raised $2.59M.
-
Who are Origo Biopharma’s investors?
Asabys Partners and XesGalicia have invested in Origo Biopharma.
-
When was Origo Biopharma acquired?
Origo Biopharma was acquired on 26-Oct-2021.
-
Who acquired Origo Biopharma?
Origo Biopharma was acquired by Agomab Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process